TGF‐β signaling is the predominant pathway to regulate podocyte EMT and contributes to the disease progress of FSGS.[15] However, little knowledge is known on how TGF‐β signaling is modulated during podocyte EMT. Here, TGFB1 is linked to focal segmental glomerulosclerosis.